| Literature DB >> 28721148 |
Huadong Bai1, Jingchun Sun2, Guiying Du3, Fengjun Jiao4.
Abstract
INTRODUCTION: Dyslipidemia is associated with increased rho-associated kinase 2 (ROCK2) concentration. Whether moderate aerobic exercise could attenuate leukocyte ROCK2 concentration is unknown.Entities:
Keywords: aerobic exercise; dyslipidemia; rho-associated kinase
Year: 2017 PMID: 28721148 PMCID: PMC5510505 DOI: 10.5114/aoms.2017.68142
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Baseline characteristics comparisons
| Variables | Exercise ( | Control ( |
|---|---|---|
| Age [years] | 49.6 ±6.3 | 48.3 ±8.1 |
| Male, | 36 (72.0) | 35 (70.0) |
| BMI [kg/m2] | 23.2 ±3.5 | 23.8 ±3.0 |
| Smoking, | 14 (28.0) | 15 (30.0) |
| SBP [mm Hg] | 118.2 ±13.6 | 120.6 ±11.5 |
| DBP [mm Hg] | 73.6 ±9.2 | 71.8 ±9.7 |
| HR [bpm] | 75.4 ±6.6 | 77.1 ±5.5 |
| TG [mmol/l] | 1.4 ±0.3 | 1.5 ±0.2 |
| TC [mmol/l] | 5.8 ±0.3 | 5.8 ±0.4 |
| LDL-C [mmol/l] | 3.9 ±0.4 | 3.8 ±0.5 |
| HDL-C [mmol/l] | 0.9 ±0.2 | 0.9 ±0.1 |
| apoA1 [mmol/l] | 1.0 ±0.3 | 1.0 ±0.2 |
| apoB100 [mmol/l] | 1.9 ±0.2 | 2.0 ±0.3 |
| Lp(a) [mg/l] | 132.4 ±15.6 | 135.7 ±17.3 |
| FBG [mmol/l] | 5.4 ±0.5 | 5.6 ±0.3 |
| Cr [µmol/l] | 93.3 ±11.5 | 91.7 ±9.4 |
| BUN [mmol/l] | 5.2 ±1.0 | 5.4 ±1.1 |
| Hs-CRP [mg/l] | 4.5 ±1.3 | 4.6 ±1.0 |
| ROCK2 concentration [mg/ml] | 38.4 ±7.5 | 40.2 ±8.2 |
| NO concentration [µmol/l] | 8.3 ±1.1 | 8.9 ±1.5 |
| Average daily exercise time [min] | 5.8 ±2.7 | 6.2 ±3.1 |
BMI – body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, HR – heart rate (beats per m inute), TG – triglyceride, TC – total cholesterol, LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, ApoA1 – apoprotein A1, apoB100 – apoprotein B100, Lp(a) – lipoprotein (a), FBG – fasting blood glucose, Cr – creatinine, BUN – blood urea nitrogen, Hs-CRP – high-sensitivity C-reactive protein.
Comparisons of characteristics 3 months later
| Variables | Exercise ( | Control ( |
|---|---|---|
| Age [years] | 50.4 ±5.8 | 48.5 ±5.3 |
| Male, | 31 (73.8) | 35 (70.0) |
| BMI [kg/m2] | 21.6 ±2.4 | 23.5 ±2.7 |
| Smoking, | 11 (26.2) | 135 (26.0) |
| SBP [mm Hg] | 113.8 ±10.3 | 118.4 ±10.7 |
| DBP [mm Hg] | 71.7 ±7.9 | 72.0 ±8.8 |
| HR [bpm] | 72.6 ±5.4 | 76.2 ±6.2 |
| TG [mmol/l] | 1.4 ±0.3 | 1.6 ±0.3 |
| TC [mmol/l] | 5.3 ±0.5 | 5.7 ±0.5 |
| LDL-C [mmol/l] | 3.1 ±0.4 | 3.8 ±0.4 |
| HDL-C [mmol/l] | 1.2 ±0.3 | 0.9 ±0.2 |
| apoA1 [mmol/l] | 1.1 ±0.2 | 0.9 ±0.2 |
| apoB100 [mmol/l] | 1.5 ±0.3 | 2.0 ±0.4 |
| Lp(a) [mg/l] | 104.6 ±10.7 | 136.8 ±18.9 |
| FBG [mmol/l] | 5.3 ±0.4 | 5.6 ±0.5 |
| Cr [µmol/l] | 94.1 ±10.7 | 93.3 ±9.0 |
| BUN [mmol/l] | 5.4 ±1.1 | 5.5 ±1.0 |
| Hs-CRP [mg/l] | 3.1 ±1.2 | 4.4 ±1.2 |
| ROCK2 concentration [mg/ml] | 27.6 ±4.3 | 34.6 ±5.2 |
| NO concentration [µmol/l] | 12.2 ±2.0 | 10.7 ±1.7 |
| Average daily exercise time [min] | 37.4 ±4.3 | 16.5 ±7.5 |
p < 0.05.